Columbia Laboratories Inc (CBRX.OQ)
CBRX.OQ on NASDAQ Stock Exchange Capital Market
0.69USD
11:39am EDT
0.69USD
11:39am EDT
Price Change (% chg)
$0.02 (+2.81%)
$0.02 (+2.81%)
Prev Close
$0.67
$0.67
Open
$0.68
$0.68
Day's High
$0.69
$0.69
Day's Low
$0.68
$0.68
Volume
600
600
Avg. Vol
72,646
72,646
52-wk High
$1.21
$1.21
52-wk Low
$0.56
$0.56
About
Columbia Laboratories, Inc. (Columbia) is engaged in the business of developing, manufacturing and selling pharmaceutical products that utilize its bioadhesive drug delivery technologies to treat various medical conditions. As of December 31, 2011, Columbia developed and brought to market five bioadhesive vaginal gel products... (more)
Overall
| Beta: | 0.95 |
| Market Cap (Mil.): | $59.60 |
| Shares Outstanding (Mil.): | 87.65 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBRX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 11.49 | 37.93 | 37.76 |
| EPS (TTM): | 0.06 | -- | -- |
| ROI: | 19.77 | 19.48 | 18.76 |
| ROE: | 21.04 | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Abbott Laboratories (ABT.N) | $36.97 | +0.34 |
| Solvay S.A. (SOLB.BR) | €104.30 | +2.50 |
| Auxilium Pharmaceuticals, Inc. (AUXL.OQ) | $19.00 | +0.64 |
| Pfizer Inc. (PFE.N) | $29.06 | -0.17 |
| Johnson & Johnson (JNJ.N) | $93.93 | +0.43 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Merck & Co., Inc. (MRK.N) | $48.19 | +0.02 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

